What are the key differences between WIPO ST.25 and the new sequence rules for applications filed after July 1, 2022?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The MPEP 2420 indicates a significant change in the rules governing…
Read MoreWhat is a “Sequence Listing” in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. A “Sequence Listing” is a separate part of a patent…
Read MoreHow is unity of invention assessed for nucleotide sequences in international patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. For international patent applications filed under the Patent Cooperation Treaty…
Read MoreCan supplemental restriction requirements be issued for applications containing nucleotide sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. Generally, supplemental restriction requirements are not issued for applications that…
Read MoreWhich nucleotides are considered “specifically defined” according to WIPO Standard ST.26?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2412.03(a), WIPO Standard ST.26 defines “specifically defined”…
Read MoreWhat does “specifically defined” mean in the context of nucleotide and amino acid sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2412.03(a), “specifically defined” refers to any amino…
Read MoreWhen do the Sequence Rules apply to patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The Sequence Rules apply to patent applications containing nucleotide sequence and/or…
Read MoreHow are nucleotide and amino acid sequences represented in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2422.01, nucleotide and amino acid sequences in…
Read MoreWhat are the requirements for sequence listings in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. The requirements for sequence listings in patent applications are outlined…
Read MoreWhat are the requirements for submitting a “Sequence Listing XML” in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-30 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2416, patent applications filed on or after…
Read More